Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Federal Trade Commission
Healthtrust
UBS
Fuji
Johnson and Johnson
QuintilesIMS
Farmers Insurance
Cerilliant

Generated: September 23, 2018

DrugPatentWatch Database Preview

Pharmalucence Company Profile

« Back to Dashboard

What is the competitive landscape for PHARMALUCENCE, and what generic and branded alternatives to PHARMALUCENCE drugs are available?

PHARMALUCENCE has fourteen approved drugs.



Summary for Pharmalucence
US Patents:0
Tradenames:14
Ingredients:13
NDAs:14

Drugs and US Patents for Pharmalucence

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmalucence CIS-MDP technetium tc-99m medronate kit INJECTABLE;INJECTION 018124-001 Approved Prior to Jan 1, 1982 RX No No ➤ Sign Up ➤ Sign Up
Pharmalucence IOBENGUANE SULFATE I 131 iobenguane sulfate i-131 INJECTABLE;INJECTION 020084-001 Mar 25, 1994 DISCN No No ➤ Sign Up ➤ Sign Up
Pharmalucence IODOHIPPURATE SODIUM I 131 iodohippurate sodium i-131 INJECTABLE;INJECTION 017313-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Pharmalucence SODIUM PERTECHNETATE TC 99M technetium tc-99m sodium pertechnetate SOLUTION;INJECTION, ORAL 017321-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Fish and Richardson
Cantor Fitzgerald
US Department of Justice
McKesson
Teva
Argus Health
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.